Merkel cell carcinoma: a case report

Abstract

Merkel cell carcinoma is a rare and aggressive cutaneous neuroendocrine malignancy that presents as a persistent red-purplish, asymptomatic and rapidly growing nodule. It typically affects sun-exposed skin of white elderly individuals. In addition, risk factors for Merkel cell carcinoma include immunosuppression, as well as the presence of multiple myeloma or a history of chronic lymphocytic leukemia.

To diagnose Merkel cell carcinoma, five criteria of the AEIOU algorithm proposed in 2008 by a group of scientists at the University of Washington are used.

From the methods of laboratory diagnostics a detailed analysis of blood is used, also a histological and immunohistochemical study is carried out . Among the methods of instrumental diagnostics, ultrasound examination of the primary tumor and groups of lymph nodes of the appropriate localization, abdominal and pelvic organs; chest X-ray and skeletal bone scintigraphy; positron emission tomography combined with X-ray computed tomography are mandatory. A sentinel node biopsy followed by histological and immunohistochemical examination is recommended in the absence of metastatic lymph node lesions.

We herein contribute by reporting a case of Merkel cell carcinoma affecting the forearm of a 51-year-old female. This clinical case confirms the aggressiveness of this type of the skin cancer as well as high possibility of misdiagnosis due to the scarce occurrence of Merkel cell carcinoma and lack of professional knowledge.

Therefore, it is important for the practitioners involved in the care of skin lesions to be aware of this condition and the need for a multidisciplinary treatment approach.

Keywords

Merkel cell carcinoma / neuroendocrine cancer of the skin / dermatology

References

[1] Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1):107–110.

[2] Toker C. Trabecular carcinoma of the skin // Arch Dermatol. 1972. Vol. 105, N 1. Р. 107–110.

[3] Bichakjian CK, Olencki T, Aasi SZ, et al. Merkel Cell Carcinoma, Version 1. NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(6):742–774. doi: 10.6004/jnccn.2018.0055

[4] Bichakjian C.K., Olencki T., Aasi S.Z., et al. Merkel Cell Carcinoma, Version 1. NCCN Clinical Practice Guidelines in Oncology // J Natl Compr Canc Netw. 2018. Vol. 16, N 6. Р. 742–774. doi: 10.6004/jnccn.2018.0055

[5] Clinical recommendations of “Merkel’s Carcinoma”. Ed. by Ya.V. Vishnevskaya, et al. Moscow: GEOTAR-Media; 2017. 29 p. (In Russ).

[6] Клинические рекомендации «Карцинома Меркеля» / под ред. Я.В. Вишневской и др. Москва: ГЭОТАР-Медиа, 2017. 29 с.

[7] Kervarrec T, Samimi M, Guyétant S, et al. Histogenesis of merkel cell carcinoma: a comprehensive review. Front Oncol. 2019;9:451. doi: 10.3389/fonc.2019.00451

[8] Kervarrec T., Samimi M., Guyétant S., et al. Histogenesis of merkel cell carcinoma: a comprehensive review // Front Oncol. 2019. Vol. 9. Р. 451. doi: 10.3389/fonc.2019.00451

[9] DeCaprio JA. Molecular pathogenesis of merkel cell carcinoma. Annu Rev Pathol. 2021;16:69–91. doi: 10.1146/annurev-pathmechdis-012419-032817

[10] DeCaprio J.A. Molecular pathogenesis of merkel cell carcinoma // Annu Rev Pathol. 2021. Vol. 16. Р. 69–91. doi: 10.1146/annurev-pathmechdis-012419-032817

[11] Schadendorf D, Lebbé C, Hausen A, et al. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer. 2017;71:53–69. doi: 10.1016/j.ejca.2016.10.022

[12] Schadendorf D., Lebbé C., Hausen A., et al. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs // Eur J Cancer. 2017. Vol. 71. Р. 53–69. doi: 10.1016/j.ejca.2016.10.022

[13] Becker JC, Kauczok CS, Ugurel S, et al. Merkel cell carcinoma: Molecular pathogenesis, clinical features and therapy. JDDG J Ger Soc Dermatology. 2008;6:709–719. doi: 10.1111/j.1610-0387.2008.06830.x

[14] Becker J.C., Kauczok C.S., Ugurel S., et al. Merkel cell carcinoma: Molecular pathogenesis, clinical features and therapy // JDDG J Ger Soc Dermatology. 2008. Vol. 6. Р. 709–719. doi: 10.1111/j.1610-0387.2008.06830.x

[15] Dellambra E, Carbone ML, Ricci F, et al. Merkel Cell Carcinoma. Biomedicines. 2021;9(7):718. doi: 10.3390/biomedicines9070718

[16] Dellambra E., Carbone M.L., Ricci F., et al. Merkel Cell Carcinoma // Biomedicines. 2021. Vol. 9, N 7. Р. 718. doi: 10.3390/biomedicines9070718

[17] Harms KL, Healy MA, Nghiem P, et al. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Ann Surg Oncol. 2016;23(11):3564. doi: 10.1245/s10434-016-5266-4

[18] Harms K.L., Healy M.A, Nghiem P., et al. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system // Ann Surg Oncol. 2016. Vol. 23, N 11. Р. 3564. doi: 10.1245/s10434-016-5266-4

[19] Schadendorf D, Lebbé C, Hausen A, et al. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer. 2017;71:53–69. doi: 10.1016/j.ejca.2016.10.022

[20] Schadendorf D., Lebbé C., Hausen A., et al. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs // Eur J Cancer. 2017. Vol. 71. Р. 53–69. doi: 10.1016/j.ejca.2016.10.022

[21] Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58(3):375. doi: 10.1016/j.jaad.2007.11.020

[22] Heath M., Jaimes N., Lemos B., et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features // J Am Acad Dermatol. 2008. Vol. 58, N 3. Р. 375. doi: 10.1016/j.jaad.2007.11.020

RIGHTS & PERMISSIONS

Eco-Vector